Department of Clinical Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland.
Scientific Student's Club at the Department of Clinical Laboratory Diagnostics, Medical University of Białystok, Białystok, Poland.
Crit Rev Clin Lab Sci. 2020 Aug;57(5):345-364. doi: 10.1080/10408363.2020.1723487. Epub 2020 Feb 14.
The spot (random) urine protein to creatinine ratio (P/C ratio) is an alternative, fast and simple method of detecting and estimating the quantitative assessment of proteinuria. The aim of the work was to review the literature concerning the usefulness of spot urine P/C ratio evaluation in the diagnosis of proteinuria in the course of kidney disease, hypertension, gestational hypertension, preeclampsia, immunological diseases, diabetes mellitus, and multiple myeloma, and in the diagnosis of proteinuria in children. We searched the PubMed and Google Scholar databases using the following keywords: proteinuria, spot urine protein to creatinine ratio, spot urine P/C ratio, protein creatinine index, PCR (protein to creatinine ratio), P/C ratio and methods, Jaffe versus enzymatic creatinine methods, urine protein methods, spot urine protein to creatinine ratio versus ACR (albumin to creatinine ratio), proteinuria versus albuminuria, limitations of the P/C ratio. More weight was given to the articles published in the last 10-20 years. A spot urine P/C ratio >20 mg/mmol (0.2 mg/mg) is the most commonly reported cutoff value for detecting proteinuria, while a P/C ratio value >350 mg/mmol (3.5 mg/mg) confirms nephrotic proteinuria. The International Society for the Study of Hypertension in Pregnancy recommends a P/C ratio of 30 mg/mmol (0.3 mg/mg) for the classification of proteinuria in pregnant women at risk of preeclampsia. A high degree of correlation was observed between P/C ratio values and the protein concentration in 24-h urine collections. The spot urine P/C ratio is a quick and reliable test that can eliminate the need for a daily 24-h urine collection. However, in doubtful situations, it is still recommended to assess proteinuria in a 24-h urine collection. The literature review indicates the usefulness of the spot P/C ratio in various disease states; therefore, this test should be available in every laboratory. However, the challenge for the primary care physician is to know the limitations of the methods used to determine the protein and creatinine concentrations that are used to calculate the P/C ratio. Moreover, the P/C ratio cutoff used should be determined in individual laboratories because it depends on the patient population and the laboratory methodologies.
尿蛋白/肌酐比值(P/C 比值)是一种替代的、快速而简单的检测方法,可以定量评估蛋白尿。本研究旨在综述有关尿蛋白/肌酐比值在肾脏病、高血压、妊娠期高血压、子痫前期、免疫性疾病、糖尿病和多发性骨髓瘤中的蛋白尿诊断以及儿童蛋白尿诊断中的作用的文献。我们使用以下关键词在 PubMed 和 Google Scholar 数据库中进行检索:蛋白尿、尿蛋白/肌酐比值、尿 P/C 比值、蛋白肌酐指数、PCR(蛋白/肌酐比值)、P/C 比值和方法、Jaffe 法与酶法肌酐、尿蛋白方法、尿蛋白/肌酐比值与 ACR(白蛋白/肌酐比值)、蛋白尿与白蛋白尿、P/C 比值的局限性。我们更注重近 10-20 年发表的文章。最常报道的检测蛋白尿的尿 P/C 比值截断值为>20mg/mmol(0.2mg/mg),而 P/C 比值>350mg/mmol(3.5mg/mg)则可确诊肾病性蛋白尿。国际妊娠高血压学会建议,对于有子痫前期风险的孕妇,尿 P/C 比值>30mg/mmol(0.3mg/mg)用于蛋白尿分类。尿 P/C 比值与 24 小时尿蛋白浓度之间存在高度相关性。尿蛋白/肌酐比值是一种快速可靠的检测方法,可以替代每日 24 小时尿收集。但在可疑情况下,仍建议进行 24 小时尿蛋白检测。文献综述表明,尿 P/C 比值在各种疾病状态下均有作用,因此每个实验室都应具备该检测方法。但基层医生的挑战是了解用于确定计算 P/C 比值的蛋白和肌酐浓度的方法的局限性。此外,由于 P/C 比值截断值取决于患者人群和实验室方法学,因此应在各个实验室确定。